Detalles de la búsqueda
1.
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Hepatology
; 78(1): 258-271, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36994719
2.
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment.
Biochem Pharmacol
; : 116249, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697308
3.
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Lancet Gastroenterol Hepatol
; 8(8): 714-725, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36958367
4.
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Contemp Clin Trials
; 134: 107352, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802221
5.
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis.
Sci Transl Med
; 12(572)2020 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33268509
6.
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.
Contemp Clin Trials
; 98: 106175, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045403
Resultados
1 -
6
de 6
1
Próxima >
>>